Tagomics Ltd has secured £860,000 in Innovate UK Biomedical Catalyst funding to develop a sophisticated diagnostic test for early colorectal cancer detection, forming part of a £1.2 million project that could transform cancer screening capabilities. The Cambridge-based biomarker discovery company will customise its proprietary Interlace platform to identify genetic and epigenetic mutations associated with colorectal […]

SpliceBio has secured US$135 million in Series B funding to tackle one of gene therapy’s most persistent technical barriers: the packaging capacity limitations that have rendered many genetic diseases untreatable. The Barcelona-based company’s breakthrough protein splicing technology promises to unlock therapeutic potential for conditions caused by genes too large for conventional delivery systems.

German biotech company osteolabs GmbH has secured a pivotal distribution partnership with leading Swiss medical laboratory ‘labor team’, bringing cutting-edge calcium isotope technology to Switzerland and Liechtenstein’s healthcare systems and with the aim of transforming bone health diagnostics for over half a million patients.

F. Hoffmann-La Roche has announced an ambitious US$50 billion investment initiative spanning five years, designed to transform the company’s United States pharmaceutical and diagnostics infrastructure. The comprehensive expansion programme addresses critical manufacturing bottlenecks whilst establishing cutting-edge research capabilities across multiple therapeutic domains, creating over 12,000 new positions in the biomedical technology sector.

Fujifilm Corporation has announced a comprehensive rebranding of its life sciences subsidiaries, positioning the conglomerate as a unified provider of end-to-end pharmaceutical development solutions. The strategic restructuring affects two major subsidiaries and reflects the company’s substantial investment commitment to the biotechnology sector.